Aditya Birla Sun Life Pharma and Healthcare Fund
Holdings
39
Concentrated
Top 10 weight
52%
Concentration
Active share
90%
Highly Differentiated
Equity
97%
Asset allocation
Portfolio
4Sectors
2Large positions
75.0%Top: Pharmaceuticals & Biotechnology
3.2%Cash
Market-cap allocation
Large cap31%
Mid cap27%
Small cap39%
Asset allocation
Equity97%
Cash3%
Top holdings
12.4%
7.3%
4.8%
4.7%
Aurobindo Pharma LimitedEQUITY
4.4%4.0%
Mankind Pharma LtdEQUITY
3.9%Lupin LimitedEQUITY
3.7%Abbott India LimitedEQUITY
3.7%3.3%
3.2%
Cipla LimitedEQUITY
3.0%Shilpa Medicare LtdEQUITY
2.9%2.4%
SAI Life Sciences LtdEQUITY
2.3%2.2%
CORONA Remedies LtdEQUITY
2.1%2.0%
1.9%
1.8%
1.8%
1.6%
1.5%
1.4%
Pfizer LimitedEQUITY
1.4%1.4%
1.2%
Biocon LimitedEQUITY
1.2%Gland Pharma LimitedEQUITY
1.2%Piramal Pharma LtdEQUITY
1.2%1.1%
1.1%
1.0%
Suraksha Diagnostic LtdEQUITY
1.0%0.75%
0.71%
Jubilant Pharmova LtdEQUITY
0.66%Vinati Organics LimitedEQUITY
0.65%AI Smart summary
Portfolio read
- 97% equity, 3% cash.
- 39 disclosed positions across 4 classified equity sectors.
- Largest equity sector is Pharmaceuticals & Biotechnology at 75.0% of the portfolio.
Watchpoints
- Small-cap exposure is 39%, which may increase volatility and liquidity risk.
- Sector concentration is elevated: Pharmaceuticals & Biotechnology represents 75%.
Auto-generated from fund metrics. Educational only - not investment advice.
Peer comparison
Other funds in Sectoral / Thematic.
JioBlackRock Sector Rotation Fund291 holdings · 33% top 10 · 36% AS
Bandhan Business Cycle Fund95 holdings · 35% top 10 · 65% AS
WhiteOak Capital Special Opportunities Fund91 holdings · 29% top 10 · 73% AS
UTI Quant Fund90 holdings · 35% top 10 · 66% AS
ICICI Prudential Manufacturing Fund86 holdings · 37% top 10 · 79% AS
Axis India Manufacturing Fund86 holdings · 34% top 10 · 73% AS
Sector exposure
Full industry / sector breakdown aggregated from the fund's holdings.
75.0%
20.1%
1.0%
0.6%